We are live on ! Find out more
SCM

Smead Capital Management Portfolio holdings

AUM $4.6B
1-Year Est. Return 27.56%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+27.56%
3 Year Est. Return
+64.97%
5 Year Est. Return
+125.46%
10 Year Est. Return
+462.58%
AUM
$1.09B
AUM Growth
+$158M
Cap. Flow
+$88.5M
Cap. Flow %
8.16%
Top 10 Hldgs %
50.67%
Holding
30
New
Increased
22
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$16.3M
2
AFL icon
Aflac
AFL
+$10.2M
3
CAB
Cabela's Inc
CAB
+$9.85M
4
NVR icon
NVR
NVR
+$9.78M
5
PFE icon
Pfizer
PFE
+$8.1M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.63M
2
AMGN icon
Amgen
AMGN
+$4.76M
3
ABT icon
Abbott
ABT
+$3.96M
4
ABBV icon
AbbVie
ABBV
+$3.33M
5
ACN icon
Accenture
ACN
+$2.75M

Sector Composition

Rank Sector Weight
1 Financials 32.11%
2 Healthcare 27.94%
3 Consumer Discretionary 24.04%
4 Communication Services 10.4%
5 Technology 2.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
26
McDonald's
MCD
$192B
$16.1M 1.48%
171,419
+15,255
+10% +$1.43M
SBUX icon
27
Starbucks
SBUX
$120B
$15.1M 1.39%
367,422
-19,976
-5% -$780K
ABT icon
28
Abbott
ABT
$183B
$11.7M 1.07%
259,009
-90,835
-26% -$3.96M
SLM icon
29
SLM Corp
SLM
$4.89B
$8.59M 0.79%
842,924
+98,229
+13% +$939K
USB icon
30
US Bancorp
USB
$98.2B
-17,784
Closed -$744K

Similar funds

Smead Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Smead Capital Management held 30 positions worth $1.09B, up 17% from $927M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Smead Capital Management deployed $88.5M of net new capital in Q4 2014, adding to 22 existing holdings.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Merck, an estimated $5.63M trimmed.

  • Smead Capital Management added most to eBay in Q4 2014, an estimated $16.3M increase.
  • Smead Capital Management's biggest Q4 2014 reduction was Merck, cutting an estimated $5.63M.
  • Smead Capital Management fully exited US Bancorp in Q4 2014, selling an estimated $744K.
  • Smead Capital Management's ten largest holdings make up 51% of its $1.09B portfolio in Q4 2014.
  • Smead Capital Management opened 0 new positions and closed 1 in Q4 2014.
  • Smead Capital Management's portfolio value rose 17% quarter-over-quarter to $1.09B.

Based on Smead Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.